http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b706e45fdecc10bbfcd58b469bb8f1f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | A. Ferrando Ferrando |
| name | Adolfo A. Ferrando Adolfo A Ferrando |
| given-name | Adolfo Adolfo A. Adolfo A |
| organization-name | Institute for Cancer Genetics 1 , 2 , and 3; Department of Pediatrics 1 , 2 , and 3; Department of Pathology, Columbia University Medical Center, New York, NY 10032 1 , 2 , and 3; Institute for Cancer Genetics 1 , 2 , and 3; Department of Pediatrics 1 , 2 , and 3; Department of Pathology, Columbia University Medical Center, New York, NY 10032 1 , 2 , and 3; Institute for Cancer Genetics 1 , 2 , and 3; Department of Pediatrics 1 , 2 , and 3; Department of Pathology, Columbia University Medical Center, New York, NY 10032 1 , 2 , and 3 1Institute for Cancer Genetics, Columbia University Irving Medical Center, New York, New York.; 9Department of Pediatrics, Columbia University Irving Medical Center, New York, New York.; 10Department of Pathology and Cell Biology, Columbia University, New York, New York.; 11Department of Systems Biology, Columbia University, New York, New York. Institute for Cancer Genetics, Columbia University, New York, NY 10032;; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032;; Department of Pediatrics, Columbia University Medical Center, New York, NY 10032 7Institute of Cancer Genetics, Columbia University, New York, New York. From the Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Pediatric Oncology, Harvard Medical School, Boston, MA; Clinical Research Institute of Montréal, Montréal, QC, Canada; and Shannon McCormack Advanced Molecular Diagnostics Laboratory, Dana-Farber Cancer Institute, Boston, MA. 1Institute for Cancer Genetics, Columbia University, New York, New York.; 2Department of Pediatrics, Columbia University Medical Center, New York, New York.; 3Department of Systems Biology, Columbia University, New York, New York.; 18Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York. Institute for Cancer Genetics, Columbia University, New York, NY;; Department of Pediatrics, Columbia University Medical Center, New York, NY;; Department of Pathology, Columbia University Medical Center, New York, NY Institute for Cancer Genetics Columbia University New York; Department of Pathology Columbia University New York; Department of Pediatrics Columbia University New York Division of Pediatric Oncology, Department of Pediatrics;; Institute for Cancer Genetics; and; Department of Pathology, Columbia University Medical Center, New York, NY; and Institute for Cancer Genetics,; Department of Pathology, and; Department of Pediatrics, Columbia University, New York, NY 10032; and Division of Pediatric Oncology, Department of Pediatrics,; Institute for Cancer Genetics,; Department of Pathology, and From the Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and the Unit of Tumor Biology, Institute of Molecular Medicine, University of Lisbon Medical School, Lisbon, Portugal. Institute for Cancer Genetics, Columbia University, New York, NY 10032;; Department of Pediatrics, Columbia University, New York, NY 10032;; Department of Pathology, Columbia University, New York, NY 10032 From the Department of Pediatric Oncology, the Department of Biostatistical Science, Cancer Immunology and AIDS, and Howard Hughes Medical Institute, Dana-Farber Cancer Institute, Boston, MA; and the Department of Medicine, Children's Hospital, Boston, MA. Institute for Cancer Genetics, Columbia University, New York, NY;; Department of Pathology and; Department of Pediatrics, Columbia University Medical Center, New York, NY †Institute for Cancer Genetics, Columbia University, New York, NY 10032; Authors' Affiliations: 1Department of Molecular and Developmental Genetics, VIB, 2Center for Human Genetics, KU Leuven, Leuven, Belgium; Departments of 3Pediatrics and 4Pathology, and 5Institute for Cancer Genetics, Columbia University, New York, New York; Authors' Affiliations: 1Department of Molecular and Developmental Genetics, VIB, 2Center for Human Genetics, KU Leuven, Leuven, Belgium; Departments of 3Pediatrics and 4Pathology, and 5Institute for Cancer Genetics, Columbia University, New York, New York; Authors' Affiliations: 1Department of Molecular and Developmental Genetics, VIB, 2Center for Human Genetics, KU Leuven, Leuven, Belgium; Departments of 3Pediatrics and 4Pathology, and 5Institute for Cancer Genetics, Columbia University, New York, New York Departments of Pediatrics and Pathology, and the Institute for Cancer Genetics, Columbia University Medical Center, New York, NY From the Department of Haematology, Cancer Institute, and University College London Hospital; Imperial College, Hammersmith Hospital Campus, London; Clinical Trial Service Unit, Oxford, United Kingdom; Department of Pediatric Oncology, Columbia University Medical Center; Institute for Cancer Genetics and Department of Pathology, Columbia University Medical Center, New York; Our Lady of Mercy Cancer Center, New York Medical College, Bronx, NY; Rambam Medical Center and Technion, Israel Institute of... Institute for Cancer Genetics, Columbia University Medical Center, New York, NY;; Department of Pediatrics and; Department of Pathology, Columbia University Medical Center, New York, NY 2Institute for Cancer Genetics, Columbia University Medical Center, New York, New York.; 6Department of Pathology, Columbia University Medical Center, New York, New York.; 7Department of Pediatrics, Columbia University Medical Center, New York, New York. Authors' Affiliations: 1Institute for Cancer Genetics, Departments of 2Pathology and 3Pediatrics, Columbia University; 4Montefiore Medical Center North, Bronx, New York; 5Pfizer Global Research and Development, Pfizer Inc., San Diego, California; 6Rambam Medical Center, Haifa, Israel; and 7Pfizer Oncology, New London, Connecticut; Authors' Affiliations: 1Institute for Cancer Genetics, Departments of 2Pathology and 3Pediatrics, Columbia University; 4Montefiore Medical Center North, Bronx, New York; 5Pfizer Global Research and Development, Pfizer Inc., San Diego, California; 6Rambam Medical Center, Haifa, Israel; and 7Pfizer Oncology, New London, Connecticut; Authors' Affiliations: 1Institute for Cancer Genetics, Departments of 2Pathology and 3Pediatrics, Columbia University; 4Montefiore Medical Center North, Bronx, New York; 5Pfizer Global Research and Development, Pfizer Inc., San Diego, California; 6Rambam Medical Center, Haifa, Israel; and 7Pfizer Oncology, New London, Connecticut Institute for Cancer Genetics, Columbia University, New York, NY, USA; Department of Pediatrics, Columbia University, New York, NY, USA; Department of Pathology, Columbia University, New York, NY, USA Institute of Cancer Genetics, Columbia University, New York, NY 10032 2Institute for Cancer Genetics, Columbia University, New York, New York.; 12Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York.; 13Department of Pediatrics, Columbia University Medical Center, New York, New York.; 14Department of Systems Biology, Columbia University, New York, New York. *Institute for Cancer Genetics and; Whitehead Institute, Cambridge, MA 02142; 1Institute for Cancer Genetics, Columbia University, New York, New York.; 2Department of Pathology, Columbia University Medical Center, New York, New York.; 3Department of Pediatrics, Columbia University Medical Center, New York, New York. Institute for Cancer Genetics, Columbia University, New York, NY 10032;; Department of Pediatrics, Columbia University Medical Center, New York, NY 10032;; Department of Pathology, Columbia University Medical Center, New York, NY 10032 Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115; Hematology/Oncology, Children's Hospital, Boston, MA 02115; and Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115 3Department of Pediatric Oncology, Dana-Farber Cancer Institute Institute for Cancer Genetics and the Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032;; Department of Pathology and Cell Biology, Columbia University, New York, NY 10032;; Department of Pediatrics, Columbia University, New York, NY 10032; 1Institute for Cancer Genetics, Columbia University, New York, New York.; 3Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey.; 10Department of Pediatrics, Columbia University Medical Center, New York, New York.; 11Department of Pathology, Columbia University Medical Center, New York, New York. 1Institute for Cancer Genetics, Columbia University, New York, NY;; 9Department of Systems Biology, Columbia University, New York, NY; and; 10Department of Pediatrics and; 11Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY Institute for Cancer Genetics, Columbia University, New York, NY;; Departments of Pediatrics and; Pathology, Columbia University Medical Center, New York, NY; Institute for Cancer Genetics, Columbia University, New York, NY; INSTITUTE FOR CANCER GENETICS AND DEPARTMENTS OF PEDIATRICS AND PATHOLOGY,, COLUMBIA UNIVERSITY 9Institute for Cancer Genetics, Columbia University, New York, New York.; 23Department of Pediatrics, Columbia University, New York, New York.; 24Department of Pathology and Cell Biology, Columbia University, New York, New York.; 25Department of Systems Biology, Columbia University, New York, New York. Department of Pediatrics,; Department of Pathology, and; Institute for Cancer Genetics, Columbia University Medical Center, New York, NY Institute of Cancer Genetics, Columbia University, New York, NY; and Institute for Cancer Genetics,; Departments of fPathology,; Pediatrics, Associate Professor of Pediatrics and Pathology, Institute for Cancer Genetics, Columbia University Medical Center, 1130 St Nicholas Avenue, ICRC-402A, New York, NY 10032, USA Institute of Cancer Genetics, Columbia University, New York, NY 5 From the Dana-Farber Cancer Institute and Children's Hospital Boston, Boston, MA; Institute for Cancer Genetics, Columbia University, New York, NY; University of New Mexico Health Sciences Center, Albuquerque, NM; Johns Hopkins Medical Institutions, Baltimore, MD; University of California-San Francisco, San Francisco, CA; St. Jude Children's Research Hospital, Memphis, TN; University of Colorado School of Medicine; and The Children's Hospital, Aurora, CO. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. From Our Lady of Mercy Cancer Center, New York Medical College, Bronx, NY; Department of Pediatric Oncology and Eastern Cooperative Oncology Group (ECOG) Statistical Center, Dana-Farber Cancer Institute, Boston, MA; University of Rochester, NY; Ireland Cancer Center, Case Western Reserve University, Cleveland, OH; Mayo Clinic, Rochester, MN; Rambam Medical Center, Haifa, Israel; Northwestern University Feinberg School of Medicine, Chicago, IL; and the Eastern Cooperative Oncology Group, Boston, MA. Departments of Pediatrics and; Pathology, Columbia University Medical Center, New York, NY;; Institute for Cancer Genetics, Columbia University Irving Cancer Research Center, New York, NY; and |
Incoming Links
Showing number of triples: 1 to 150 of 150.